Biomedical nanoparticles modulate specific CD4<sup>+</sup>T cell stimulation by inhibition of antigen processing in dendritic cells

Fabian Blank, Peter Arne Gerber, Barbara Rothen‐Rutishauser, Usawadee Sakulkhu, Jatuporn Salaklang, K de Peyer, Peter Gehr, Laurent Nicod, Heinrich Hofmann, Thomas Geiser,

Nanotoxicology · 2011 · 94 citations · 40 references

DOIFull text

Open access

Concepts

Abstract

Understanding how nanoparticles may affect immune responses is an essential prerequisite to developing novel clinical applications. To investigate nanoparticle-dependent outcomes on immune responses, dendritic cells (DCs) were treated with model biomedical poly(vinylalcohol)-coated super-paramagnetic iron oxide nanoparticles (PVA-SPIONs). PVA-SPIONs uptake by human monocyte-derived DCs (MDDCs) was analyzed by flow cytometry (FACS) and advanced imaging techniques. Viability, activation, function, and stimulatory capacity of MDDCs were assessed by FACS and an in vitro CD4+ T cell assay. PVA-SPION uptake was dose-dependent, decreased by lipopolysaccharide (LPS)-induced MDDC maturation at higher particle concentrations, and was inhibited by cytochalasin D pre-treatment. PVA-SPIONs did not alter surface marker expression (CD80, CD83, CD86, myeloid/plasmacytoid DC markers) or antigen-uptake, but decreased the capacity of MDDCs to process antigen, stimulate CD4+ T cells, and induce cytokines. The decreased antigen processing and CD4+ T cell stimulation capability of MDDCs following PVA-SPION treatment suggests that MDDCs may revert to a more functionally immature state following particle exposure.

References

40